Trupanion Inc (NYSE:TRUP) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Friday.
According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
Several other research analysts also recently commented on TRUP. RBC Capital Markets set a $18.00 target price on Trupanion and gave the stock a “buy” rating in a report on Tuesday, September 20th. Stifel Nicolaus lifted their target price on Trupanion from $17.00 to $20.00 and gave the stock a “buy” rating in a report on Wednesday, August 3rd. Finally, Canaccord Genuity reissued a “buy” rating and issued a $19.00 price objective on shares of Trupanion in a research note on Thursday, August 4th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Trupanion presently has an average rating of “Buy” and an average price target of $16.00.
Trupanion (NYSE:TRUP) opened at 16.75 on Friday. Trupanion has a 12 month low of $7.61 and a 12 month high of $17.68. The company’s market cap is $489.99 million. The company has a 50-day moving average of $16.12 and a 200 day moving average of $15.19.
Trupanion (NYSE:TRUP) last announced its earnings results on Tuesday, November 1st. The company reported ($0.06) EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.06). The company had revenue of $48.40 million for the quarter, compared to analyst estimates of $48.17 million. The firm’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.17) earnings per share. On average, equities analysts forecast that Trupanion will post ($0.23) earnings per share for the current fiscal year.
In related news, Director Howard E. Rubin sold 21,379 shares of the business’s stock in a transaction dated Tuesday, August 30th. The stock was sold at an average price of $14.95, for a total value of $319,616.05. Following the completion of the sale, the director now directly owns 146,579 shares of the company’s stock, valued at approximately $2,191,356.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Howard E. Rubin sold 21,249 shares of the business’s stock in a transaction dated Wednesday, November 23rd. The shares were sold at an average price of $17.01, for a total value of $361,445.49. Following the completion of the sale, the director now directly owns 41,294 shares of the company’s stock, valued at $702,410.94. The disclosure for this sale can be found here.
A number of hedge funds have recently modified their holdings of the stock. Emerald Acquisition Ltd. purchased a new stake in shares of Trupanion during the second quarter worth approximately $529,000. Royce & Associates LP bought a new stake in shares of Trupanion during the second quarter worth approximately $398,000. RMB Capital Management LLC bought a new stake in shares of Trupanion during the second quarter worth approximately $1,642,000. California Public Employees Retirement System raised its stake in shares of Trupanion by 80.4% in the second quarter. California Public Employees Retirement System now owns 45,100 shares of the company’s stock worth $598,000 after buying an additional 20,100 shares in the last quarter. Finally, Thompson Davis & CO. Inc. bought a new stake in shares of Trupanion during the second quarter worth approximately $181,000.
Trupanion Company Profile
Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.